TBRG · As filed with the SEC
TruBridge income statement, by quarter
The statement as TruBridge presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS · USD thousands, except per-share amounts; shares in thousands
| USD thousands, except per-share amounts; shares in thousands | Q1 2026 3 months ended Mar 31, 2026 | Q4 2025† 3 months ended Dec 31, 2025 | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024 3 months ended Sep 30, 2024 | Q2 2024† 3 months ended Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| Total revenues | 86,271 | 87,793† | 86,106 | 85,729 | 87,208 | 88,230† | 83,830 | 84,730 |
| RCM | — | — | — | — | — | — | — | 54,108 |
| EHR | — | — | — | — | — | — | — | 30,622 |
| Financial Health | 53,274 | 56,739† | 54,501 | 54,284 | 56,133 | 55,052† | 54,271 | 54,509† |
| Patient Care | 32,997 | 31,054† | 31,605 | 31,445 | 31,075 | 33,178† | 29,559 | 31,091† |
| Expenses | ||||||||
| Costs of revenues (exclusive of amortization and depreciation) | ||||||||
| Total costs of revenues (exclusive of amortization and depreciation) | 38,348 | 40,143† | 42,048 | 41,270 | 39,513 | 41,059† | 42,369 | 43,342 |
| RCM | — | — | — | — | — | — | — | 30,269 |
| EHR | — | — | — | — | — | — | — | 13,073 |
| Financial Health | 27,254 | 28,056† | 29,335 | 29,308 | 27,192 | 27,840† | 29,185 | 30,269† |
| Patient Care | 11,094 | 12,087† | 12,713 | 11,962 | 12,321 | 13,219† | 13,184 | 13,075† |
| Product development | 7,445 | 8,027† | 8,171 | 8,113 | 8,247 | 7,827† | 7,735 | 8,207 |
| Sales and marketing | 6,388 | 4,386† | 5,673 | 8,041 | 5,409 | 6,708† | 5,944 | 7,815 |
| General and administrative | 24,162 | 23,730† | 19,416 | 18,076 | 19,464 | 19,341† | 19,376 | 18,878 |
| Amortization | 6,599 | 6,284† | 6,487 | 6,290 | 6,124 | 6,469† | 6,183 | 9,107 |
| Depreciation | 271 | 246† | 243 | 312 | 291 | 267† | 279 | 400 |
| Total expenses | 83,213 | 82,816† | 82,038 | 82,102 | 79,048 | 81,671† | 81,886 | 87,749 |
| Operating income | 3,058 | 4,977† | 4,068 | 3,627 | 8,160 | 6,559† | 1,944 | (3,019) |
| Other (expense) income: | ||||||||
| Interest expense | (2,630) | (2,866)† | (3,003) | (3,065) | (3,382) | (3,821)† | (4,033) | (4,242) |
| Other income | 154 | (5,213)† | 287 | 136 | 144 | (1,809)† | (376) | 91 |
| Total other expense | (2,476) | (8,079)† | (2,716) | (2,929) | (3,238) | (5,630)† | (4,409) | (4,151) |
| Income before taxes | 582 | (3,102)† | 1,352 | 698 | 4,922 | 929† | (2,465) | (7,170) |
| Provision for income taxes | 76 | 1,185† | (4,250) | (1,882) | 4,463 | 5,978† | 7,344 | (2,121) |
| Net income | 506 | (4,287)† | 5,602 | 2,580 | 459 | (5,049)† | (9,809) | (5,049) |
| Net income per common share—basic (in dollars per share) | 0.03 | — | 0.37 | 0.17 | 0.03 | — | (0.66) | (0.34) |
| Net income per common share—diluted (in dollars per share) | 0.03 | — | 0.37 | 0.17 | 0.03 | — | (0.66) | (0.34) |
| Weighted average shares outstanding used in per common share computations: | ||||||||
| Basic (in shares) | 14,565 | — | 14,527 | 14,522 | 14,370 | — | 14,323 | 14,313 |
| Diluted (in shares) | 14,565 | — | 14,527 | 14,522 | 14,370 | — | 14,323 | 14,313 |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.
